{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T20:51:18Z","timestamp":1764276678817,"version":"3.44.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.ejphar.2013.05.015","type":"journal-article","created":{"date-parts":[[2013,5,23]],"date-time":"2013-05-23T10:32:22Z","timestamp":1369305142000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of \u03bc-opioid receptor agonist-induced physical dependence"],"prefix":"10.1016","volume":"715","author":[{"given":"Tomohisa","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Komiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Uzawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimasa","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyou","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Shibasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.05.015_bib1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0016-5085(84)80063-3","article-title":"Colonic secretion mediated by prostaglandin E2 and 5-hydroxytryptamine may contribute to diarrhea due to morphine withdrawal in the rat","volume":"87","author":"Beubler","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2013.05.015_bib2","first-page":"MS28","article-title":"Mu opioid receptor subtypes","volume":"10","author":"Cadet","year":"2004","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejphar.2013.05.015_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0022-3565(25)21702-5","article-title":"An antiabsorptive basis for precipitated withdrawal diarrhea in morphine-dependent rats","volume":"228","author":"Chang","year":"1984","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.05.015_bib4","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0922-4106(94)90072-8","article-title":"Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine","volume":"268","author":"Elliott","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.015_bib5","first-page":"867","article-title":"Time course of dependence and tolerance development in rats treated with \u201cslow release\u201d morphine suspensions","volume":"5","author":"Frederickson","year":"1973","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.015_bib6","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0022-3565(25)10594-6","article-title":"Modification of mu-opioid agonist-induced locomotor activity and development of morphine dependence by diabetes","volume":"274","author":"Kamei","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.05.015_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00430485","article-title":"Induction of physical dependence in rats by short interval medication","volume":"50","author":"Koga","year":"1976","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejphar.2013.05.015_bib8","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1440-1681.1976.tb00640.x","article-title":"Physical dependence in the rat induced by slow release morphine: dose-response, time course and brain biogenic amines","volume":"3","author":"Laska","year":"1976","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejphar.2013.05.015_bib9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s12325-010-0063-0","article-title":"The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review","volume":"27","author":"Leppert","year":"2010","journal-title":"Adv. Ther"},{"issue":"4673","key":"10.1016\/j.ejphar.2013.05.015_bib10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1126\/science.6541807","article-title":"Separation of morphine analgesia from physical dependence","volume":"226","author":"Ling","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.05.015_bib11","first-page":"19778","article-title":"Truncated G protein\u2013coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects","volume":"108","author":"Majumdar","year":"2011"},{"key":"10.1016\/j.ejphar.2013.05.015_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/jaoac\/94.1.136","article-title":"Development and validation of an HPLC\/MS\/MS method for the determination of sufentanil and morphine in human plasma","volume":"94","author":"Manfio","year":"2011","journal-title":"J. AOAC. Int."},{"key":"10.1016\/j.ejphar.2013.05.015_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1254\/jphs.09139FP","article-title":"Morphine, oxycodone, fentanyl exhibit different analgesic profiles in mouse pain model","volume":"111","author":"Minami","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2013.05.015_bib14","first-page":"366","article-title":"Involvement of mu-opioid receptor in the salsolinol-assocxiated place preference in rats exposed to conditioned fear stress","volume":"24","author":"Matsuzawa","year":"2000","journal-title":"Alcohol Clin. Exp. Res"},{"key":"10.1016\/j.ejphar.2013.05.015_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1097\/FBP.0b013e3282f18da6","article-title":"Comparison of nitric oxide synthase inhibitors, phospholipase A2 inhibitor and free radical scavengers as attenuators of opioid withdrawal syndrome","volume":"18","author":"Mori","year":"2007","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.015_bib16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3109\/15360288.2011.620689","article-title":"Distinct relations among plasma concentrations required for different pharmacological effects in oxycodone, morphine and fentanyl","volume":"25","author":"Nakamura","year":"2011","journal-title":"J. Pain Palliat. Care Pharmacother."},{"key":"10.1016\/j.ejphar.2013.05.015_bib17","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/S0024-3205(01)01550-8","article-title":"Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites","volume":"70","author":"Narita","year":"2002","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2013.05.015_bib18","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1111\/j.1460-9568.2003.03052.x","article-title":"Reduced expression of a novel mu-opioid receptor (MOR) subtype MOR-1B in CXBK mice: implications of MOR-1B in the expression of MOR-mediated responses","volume":"18","author":"Narita","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.05.015_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002826-199302000-00001","article-title":"Pharmacological mechanisms of opioid analgesics","volume":"16","author":"Pasternak","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.ejphar.2013.05.015_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1056-8719(98)00047-1","article-title":"A study on seasonal variation in the development of morphine dependence in rats","volume":"40","author":"Salem","year":"1998","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2013.05.015_bib21","first-page":"39","article-title":"Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patient","volume":"7","author":"Slatkin","year":"2009","journal-title":"J. Support Oncol."},{"key":"10.1016\/j.ejphar.2013.05.015_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/0024-3205(92)90203-2","article-title":"The role of mu1 receptor in physical dependence on morphine using the mu receptor deficient CXBK mouse","volume":"50","author":"Suzuki","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2013.05.015_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0014-2999(95)00440-V","article-title":"Discriminative stimulus properties of morphine mediated by mu 1-opioid receptors","volume":"284","author":"Suzuki","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.05.015_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0278-5846(83)90090-8","article-title":"Development of physical dependence on and tolerance to morphine in rats treated with morphine-admixed food","volume":"7","author":"Suzuki","year":"1983","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2013.05.015_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0091-3057(96)00319-X","article-title":"Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice","volume":"57","author":"Suzuki","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.05.015_bib26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0022-3565(25)29935-9","article-title":"Induction of physical dependence on morphine, codeine and meperidine in the rat by continuous infusion","volume":"190","author":"Teiger","year":"1974","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.05.015_bib27","first-page":"6181","article-title":"Classification of multiple morphine and enkephalin binding sites in the central nervous system","volume":"78","author":"Wolozin","year":"1981"},{"key":"10.1016\/j.ejphar.2013.05.015_bib28","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMp0908913","article-title":"A difficult balance--pain management, drug safety, and the FDA","volume":"361","author":"Woodcock","year":"2009","journal-title":"N. Engl. J. Med."},{"year":"1996","series-title":"Cancer Pain Relief","author":"World Health Organization","key":"10.1016\/j.ejphar.2013.05.015_bib29"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913004007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913004007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:18:33Z","timestamp":1757974713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913004007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":29,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0014299913004007"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.05.015","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of \u03bc-opioid receptor agonist-induced physical dependence","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}